Microbot Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Microbot Medical generated cash of -$8,533,000, which is more than the previous year. Cash used in financing activities reached the amount of $6,558,000 last year. Net change in cash is therefore -$2,000.
Cash Flow
| 2014 | -27.35M | -425.62K | 22.19M |
|---|---|---|---|
| 2015 | -30.67M | -885.28K | 18.70M |
| 2016 | -786K | -25K | 3.08K |
| 2017 | -4.85M | -85K | 13.01K |
| 2018 | -5.31M | -223K | -18K |
| 2019 | -6.45M | -2.45M | 36.77M |
| 2020 | -7.25M | -2.76M | -3.37K |
| 2021 | -9.35M | 3.2M | 0 |
| 2022 | -11.54M | -3.83M | 4.32M |
| 2023 | -8.53M | 1.97M | 6.55M |
MBOT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.51M | 13.58M | 19.73M | 33.12M | 5.26M | 10.81M | 2.70M | 437K | 24.98M | 30.58M |
Operating activities | ||||||||||
Net income | -10.74M | -13.16M | -11.31M | -9.16M | -7.24M | -7.24M | -7.58M | -9.66M | -36.41M | -32.74M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 106K | 102K | 76K | 68K | 84K | 54K | 21K | 10K | 1.12M | 1.30M |
Stock-based compensation expense | 1.39M | 1.75M | 1.38M | 1.93M | 1.09M | 0 | 479K | 676K | 4.24M | 2.03M |
| Deferred income tax benefit | 1.39M | 1.75M | 1.38M | 1.93M | 1.09M | 0 | 479K | 676K | 4.24M | 2.03M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | -40K | -14K | 538K | 155.41K | -55.45K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.09M | -255.47K |
Accounts payable | 0 | 0 | 0 | 0 | -140K | 463K | 0 | 0 | 292.19K | 2.05M |
Cash generated by operating activities | -8.53M | -11.54M | -9.35M | -7.25M | -6.45M | -5.31M | -4.85M | -786K | -30.67M | -27.35M |
Investing activities | ||||||||||
Purchases Of Investments | -10.06M | -3.75M | 0 | -4.99M | -2.49M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -33K | -84K | -69K | -91K | -216K | -223K | -58K | -25K | -1.05M | -903.94K |
Acquisitions Net | 0 | 0 | 0 | 0 | 259K | 0 | 0 | 0 | 168.71K | 0 |
Cash generated by investing activities | 1.97M | -3.83M | 3.2M | -2.76M | -2.45M | -223K | -85K | -25K | -885.28K | -425.62K |
Financing activities | ||||||||||
Common Stock Issued | 6.55M | 4.32M | 0 | -3.37M | 36.77M | 0 | 12.70M | 0 | 26.32M | 18.94M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -3.37K | 0 | 0 | 0 | 0 | -392.58K | -499.33K |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 750 | 413K | -4.00M |
Cash used in financing activities | 6.55M | 4.32M | 0 | -3.37K | 36.77M | -18K | 13.01K | 3.08K | 18.70M | 22.19M |
Net Change In Cash | -2K | -11.06M | -6.15M | -13.39M | 27.86M | -5.55M | 8.07M | 2.27M | -12.87M | -5.59M |
Cash at end of period | 2.51M | 2.51M | 13.58M | 19.73M | 33.12M | 5.26M | 10.78M | 2.70M | 12.11M | 24.98M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |